Vaccines. Vaxchora® (lyophilized CVD 103-HgR). In: CDC. 18. November 2020, abgerufen am 6. Dezember 2020 (englisch).
doi.org
Lina Odevall et al.: The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships. In: Vaccine. Band36, Nr.45, 29. Oktober 2018, S.6606–6614, doi:10.1016/j.vaccine.2018.09.026, PMID 30314912, PMC 6203809 (freier Volltext).
Tarun Saluja et al.: An overview of VaxchoraTM, a live attenuated oral cholera vaccine. In: Human Vaccines & Immunotherapeutics. Band16, Nr.1, 20. September 2019, S.42–50, doi:10.1080/21645515.2019.1644882, PMID 31339792, PMC 7012186 (freier Volltext).
Graves PM, Deeks JJ, Demicheli V, Jefferson T: Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected). In: Cochrane Database Syst Rev. Nr.8, 2010, S.CD000974, doi:10.1002/14651858.CD000974.pub2, PMID 20687062.
google.ca
books.google.ca
Lawrence R. Stanberry: Vaccines for biodefense and emerging and neglected diseases. 1. Auflage. Academic, Amsterdam 2009, ISBN 978-0-08-091902-7, S.870 (google.ca).
nih.gov
ncbi.nlm.nih.gov
Cholera vaccines: WHO position paper – August 2017. In: Wkly Epidemiol Rec. Band92, Nr.34, 25. August 2017, S.477–498, PMID 28845659.
Lina Odevall et al.: The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships. In: Vaccine. Band36, Nr.45, 29. Oktober 2018, S.6606–6614, doi:10.1016/j.vaccine.2018.09.026, PMID 30314912, PMC 6203809 (freier Volltext).
Tarun Saluja et al.: An overview of VaxchoraTM, a live attenuated oral cholera vaccine. In: Human Vaccines & Immunotherapeutics. Band16, Nr.1, 20. September 2019, S.42–50, doi:10.1080/21645515.2019.1644882, PMID 31339792, PMC 7012186 (freier Volltext).